Great post. I'm very excited for 2021. Looks like it could be a good year for CYP with them moving forward with some big investors backing them. Time for Cynata to be recognised as a new leader in cellular medicine.
The science is continually evolving and Cynata is in prime position to learn from it's bigger brother and take the lead.
These shares under 70 cents the last few days were an earlier Christmas present
Merry Christmas fellow cynatas
CYNATA - 2021 The Year of Multiple Trials, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 25.5¢ | $10.03K | 38.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27654 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 14.08pm 17/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |